Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of human NSCLCL treated with Alectinib, Lorlatinib or Brigatinib

ABSTRACT: RNA-seq of human NSCLCL treated with Alectinib, Lorlatinib or Brigatinib

PROVIDER: PRJEB50324 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR8057700_1.fastq.gz	Fastqsanger.gz
	ERR8057700_2.fastq.gz	Fastqsanger.gz
	ERR8057710_1.fastq.gz	Fastqsanger.gz
	ERR8057710_2.fastq.gz	Fastqsanger.gz
	ERR8057720_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 180

Similar Datasets

RNA-seq of human NSCLCL treated with Alectinib, Lorlatinib or Brigatinib

Project description:To better understand the differences between different ALK inhibitors on ALK positive NSCL cell lines, we performed RNA-seq analysis on samples treated with 3 types of ALK inhibitors: Alectinib, Lorlatinib and Brigatinib

2022-07-26 | E-MTAB-11342 | biostudies-arrayexpress

RNA-seq of human neuroblastoma cell lines treated with ALKAL2 and/or lorlatinib

Project description:RNA-seq of human neuroblastoma cell lines treated with ALKAL2 and/or lorlatinib

| PRJEB40483 | ENA

RNA-seq of human NSCLC cell line treated with Tramatinib or Lorlatinib, at different time points

Project description:To better understand the differences between different ALK inhibitors on ALK positive NSCLC cell lines, we performed RNA-seq analysis on samples treated with 2 types of ALK inhibitors: Tramatinib and Lorlatinib. Samples taken 6h and 24h after treatment

2023-01-26 | E-MTAB-11834 | biostudies-arrayexpress

A Comparative Study of Human Testes and Epididymis through the Proteomics and RNA-seq Methods

Project description:A Comparative Study of Human Testes and Epididymis through the Proteomics and RNA-seq Methods

2021-06-03 | PXD026440 |

RNA-seq of human NSCLC cell line treated with Tramatinib or Lorlatinib, at different time points

Project description:RNA-seq of human NSCLC cell line treated with Tramatinib or Lorlatinib, at different time points

| PRJEB53629 | ENA

RNA-seq of CYR61-treated THP1 human monocytes

Project description:RNA-seq of CYR61-treated THP1 human monocytes

| PRJNA975085 | ENA

Microarray analysis of drug-tolerant cells in ALK-rearranged non-small cell lung cancer cell lines induced by ALK-TKIs

Project description:To investigate the molecular mechanisms underlying the emergence and maintenance of drug-tolerant (DT) cells in anaplastic lymphoma kinase (ALK)-rearranged lung cancer, we isolated DT cells from H2228 and A925L cells exposed to high doses of alectinib or lorlatinib for 9 days, and performed transcriptome analysis between parental and DT cells using a gene expression microarray.

2021-11-09 | GSE188406 | GEO

RNA-seq of SPARC-treated human corneal epithelial cells

Project description:RNA-seq of SPARC-treated human corneal epithelial cells

| PRJNA888997 | ENA

Transcriptome (RNA-seq) of statin-treated human primary myotubes

Project description:Transcriptome (RNA-seq) of statin-treated human primary myotubes

| PRJNA422136 | ENA

Single cell RNA-seq for LPS-treated human monocytes

Project description:Single cell RNA-seq for LPS-treated human monocytes

| PRJNA667721 | ENA